¡Ya estamos en ! Descubre más
SYNH

Syneos Health, Inc. Class A Common Stock

Excluida de cotización

SYNH dejó de cotizar en bolsa el 27 de septiembre de 2023.

 

Acerca de: Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Empleados: 29,395

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%

No hemos recibido artículos de noticias recientes sobre SYNH.

Gráficos de precios implementados con Lightweight Charts™